Oncolytic bacteria are a type of bacteria specifically engineered or naturally capable of targeting and killing cancer cells. These bacteria can selectively infect and proliferate within tumors, leading to the destruction of cancer cells while sparing normal tissue. The concept of using bacteria in cancer therapy is not new and dates back to the early 20th century. However, advancements in genetic engineering and microbiology have revitalized interest in this approach.
